Your browser doesn't support javascript.
loading
The impact of diabetes and metabolic syndromes to the effectiveness of cyclosporine a pharmacotherapy in psoriatic patients.
Michalska-Bankowska, Anna; Grabarek, Beniamin; Wcislo-Dziadecka, Dominika; Gola, Joanna.
  • Michalska-Bankowska A; Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, Sosnowiec, Poland.
  • Grabarek B; Department of Molecular Biology, School of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland.
  • Wcislo-Dziadecka D; Department of Cosmetology, School of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland.
  • Gola J; Department of Molecular Biology, School of Pharmacy with Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland.
Dermatol Ther ; 32(3): e12881, 2019 05.
Article en En | MEDLINE | ID: mdl-30945797
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Ciclosporina / Síndrome Metabólico / Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Ciclosporina / Síndrome Metabólico / Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article